×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Alimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Down 14.6% in May
Defense World
Read Alimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Down 14.6% in May at Defense World.
5 days ago
Alimera Sciences Inc (ALIM) Reports Significant Revenue Growth in Q4 and Full Year 2023
Yahoo Finance
Alimera Sciences Inc (ALIM) Reports Significant Revenue Growth in Q4 and Full Year 2023 · Q4 Net Revenue: Increased by 88% to $26.3 million...
2 months ago
Short Interest in Alimera Sciences, Inc. (NASDAQ:ALIM) Declines By 14.6%
MarketBeat
Alimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the recipient of a large drop in short interest during the month of May.
5 days ago
Alimera Sciences: Q1 Earnings Snapshot
Houston Chronicle
ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Alimera Sciences Inc. (ALIM) on Tuesday reported a loss of $6.3 million in its first quarter.
3 weeks ago
Alimera Sciences, Inc. (ALIM) Q1 2024 Earnings Call Transcript
Seeking Alpha
Alimera Sciences, Inc. (NASDAQ:NASDAQ:ALIM) Q1 2024 Earnings Conference Call May 14, 2024 9:00 AM ETCompany ParticipantsScott Gordon - CORE...
3 weeks ago
Alimera Sciences Reports Financial Results for First Quarter of 2024
Vision Monday
ATLANTA—Alimera Sciences, Inc., a global pharmaceutical company specializing in retinal health, has announced financial results for the...
3 weeks ago
ALIM Stock Quote Price and Forecast
CNN
View Alimera Sciences, Inc. ALIM stock quote prices, financial information, real-time forecasts, and company news from CNN.
3 months ago
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing ...
GlobeNewswire
ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical...
5 months ago
Alimera Sciences, Inc. (NASDAQ:ALIM) Has Found A Path To Profitability
Yahoo Finance
Alimera Sciences is bordering on breakeven, according to the 3 American Pharmaceuticals analysts. They expect the company to post a final loss...
2 months ago
Alimera Sciences, Inc. (ALIM) Q4 2023 Earnings Call Transcript
Seeking Alpha
Alimera Sciences, Inc. (NASDAQ:NASDAQ:ALIM) Q4 2023 Earnings Conference Call March 7, 2024 9:00 AM ETCompany ParticipantsScott Gordon - CORE...
2 months ago